Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

293 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety, Feasibility and Technical Considerations from a Prospective, Observational Study-CIREL: Irinotecan-TACE for CRLM in 152 Patients.
Helmberger T, Lucatelli P, Pereira PL, Gjoreski A, Jovanoska I, Bansaghi Z, Spiliopoulos S, Carchesio F, Arnold D, Baierl A, Zeka B, Kaufmann NC, Taieb J, Iezzi R. Helmberger T, et al. Among authors: iezzi r. J Clin Med. 2022 Oct 19;11(20):6178. doi: 10.3390/jcm11206178. J Clin Med. 2022. PMID: 36294499 Free PMC article.
Transcatheter Arterial Embolization for Bleeding Peptic Ulcers: A Multicenter Study.
Spiliopoulos S, Inchingolo R, Lucatelli P, Iezzi R, Diamantopoulos A, Posa A, Barry B, Ricci C, Cini M, Konstantos C, Palialexis K, Reppas L, Trikola A, Nardella M, Adam A, Brountzos E. Spiliopoulos S, et al. Among authors: iezzi r. Cardiovasc Intervent Radiol. 2018 Sep;41(9):1333-1339. doi: 10.1007/s00270-018-1966-4. Epub 2018 Apr 18. Cardiovasc Intervent Radiol. 2018. PMID: 29671058
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib.
Iezzi R, Pompili M, Rinninella E, Annicchiarico E, Garcovich M, Cerrito L, Ponziani F, De Gaetano A, Siciliano M, Basso M, Zocco MA, Rapaccini G, Posa A, Carchesio F, Biolato M, Giuliante F, Gasbarrini A, Manfredi R; HepatoCatt Study Group. Iezzi R, et al. Eur Radiol. 2019 Mar;29(3):1285-1292. doi: 10.1007/s00330-018-5692-8. Epub 2018 Aug 31. Eur Radiol. 2019. PMID: 30171360
Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible?
Iezzi R, Pompili M, Posa A, Carchesio F, Siciliano M, Annicchiarico BE, Agnes S, Giuliante F, Garcovich M, Cerrito L, Ponziani FR, Basso M, Cassano A, Rapaccini GL, De Gaetano AM, Gasbarrini A, Manfredi R; HepatoCATT Study Group for the Multidisciplinary Management of HCC. Iezzi R, et al. Eur J Radiol. 2019 May;114:32-37. doi: 10.1016/j.ejrad.2019.02.030. Epub 2019 Feb 23. Eur J Radiol. 2019. PMID: 31005173
Immuno-oncology and interventional oncology: a winning combination. The latest scientific evidence.
Lucatelli P, Iezzi R, De Rubeis G, Goldberg SN, Bilbao JI, Sami A, Akhan O, Giuliante F, Pompili M, Tagliaferri L, Valentini V, Gasbarrini A, Colosimo C, Bezzi M, Manfredi R. Lucatelli P, et al. Among authors: iezzi r. Eur Rev Med Pharmacol Sci. 2019 Jun;23(12):5343-5350. doi: 10.26355/eurrev_201906_18201. Eur Rev Med Pharmacol Sci. 2019. PMID: 31298386 Free article. Review.
Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of patients with lung tumors.
Iezzi R, Larici AR, Posa A, Carchesio F, Congedo MT, Tagliaferri L, Cassano A, D'argento E, Mantini G, Rodolfino E, Margaritora S, Bria E, Tortora G, Valentini V, Manfredi R. Iezzi R, et al. Eur Rev Med Pharmacol Sci. 2019 Aug;23(15):6554-6561. doi: 10.26355/eurrev_201908_18541. Eur Rev Med Pharmacol Sci. 2019. PMID: 31378896 Free article. Clinical Trial.
293 results